Peter Ringrose
Corporate Officer/Principal presso The Foundation for Science & Technology
Profilo
Peter S.
Ringrose is currently the Chairman of the Corporate Partnership Board at Pembroke College Cambridge and a Council Member at The Foundation for Science & Technology.
He previously served as the Chairman of the Biotechnology & Biological Sciences Research Council from 2003 to 2009.
He also held positions as a Director at ImClone LLC, an Independent Director at Rigel Pharmaceuticals, Inc. from 2005 to 2019, and a Director at MedImmune Ltd.
in 2006.
Additionally, he served as a Non-Executive Director at Biotica Technology Ltd.
from 2005 to 2013 and as a Director at Astex Therapeutics Ltd.
in 2011.
He was an Independent Non-Executive Director at Innoviva, Inc. from 2010 to 2014.
Dr. Ringrose has also held positions as a Division Director-Chemotherapy at Sandoz Research Institute and as a Senior Vice President-Worldwide Drug Discovery at Pfizer Inc. from 1982 to 1996.
He was a Member of Innovate UK in 2009 and a Member of the Governors Board at the New York Academy of Sciences from 1999 to 2005.
He served as the President & Chief Scientific Officer at Bristol-Myers Squibb Pharmaceutical Research Institute from 2002 to 2002 and as the President of the Pharmaceutical Research Institute from 1997 to 2002.
Dr. Ringrose obtained his undergraduate, graduate, and doctorate degrees from the University of Cambridge.
Posizioni attive di Peter Ringrose
| Società | Posizione | Inizio |
|---|---|---|
The Foundation for Science & Technology
 The Foundation for Science & Technology Miscellaneous Commercial ServicesCommercial Services The Foundation for Science & Technology provide a neutral platform for debate of policy issues that have a science, technology or medical element. The company is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
| Pembroke College Cambridge | Corporate Officer/Principal | - |
Precedenti posizioni note di Peter Ringrose
| Società | Posizione | Fine |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Direttore/Membro del Consiglio | 28/04/2020 |
| RIGEL PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 22/05/2019 |
| INNOVIVA, INC. | Direttore/Membro del Consiglio | 04/05/2014 |
Biotica Technology Ltd.
 Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | Direttore/Membro del Consiglio | 01/12/2013 |
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | - |
Formazione di Peter Ringrose
| University of Cambridge | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| INNOVIVA, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| Aziende private | 13 |
|---|---|
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Biotechnology & Biological Sciences Research Council
 Biotechnology & Biological Sciences Research Council Miscellaneous Commercial ServicesCommercial Services Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom. | Commercial Services |
The Foundation for Science & Technology
The Foundation for Science & Technology Miscellaneous Commercial ServicesCommercial Services The Foundation for Science & Technology provide a neutral platform for debate of policy issues that have a science, technology or medical element. The company is headquartered in London, the United Kingdom. | Commercial Services |
Biotica Technology Ltd.
Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | Health Technology |
Schering-Plough Holdings Ltd.
 Schering-Plough Holdings Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Holdings Ltd. develops and manufactures pharmaceutical products. It offers sterilization tablets, cotton buds, and animal & veterinary health products. The company is headquartered in Welwyn Garden City, UK. | Health Technology |
| Sandoz Research Institute | |
New York Academy of Sciences
 New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Commercial Services |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Health Technology |
Innovate UK
 Innovate UK Miscellaneous Commercial ServicesCommercial Services Innovate UK promotes, supports and invests in technology research, development, and commercialization. The firm provides access to information about the funding and support opportunities through a range of channels. The company was founded on July 1, 2007 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
| Bristol-Myers Squibb Pharmaceutical Research Institute | |
| Pharmaceutical Research Institute |
- Borsa valori
- Insiders
- Peter Ringrose
